Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Hall

Showing results (91-100 of 151) with videos related to

Pageof 16
Sort By:
Cancer|April 1, 1990
The epidermal growth factor receptor and the prognosis of bladder cancerD E Neal, L Sharples, K Smith, et al.
The Journal of Urology|May 9, 2001
Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumorsJ Palou, P Laguna, F Millán-Rodríguez, et al.
The Journal of Urology|March 1, 1989
Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand bindingD E Neal, K Smith, J A Fennelly, et al.
British Medical Journal|September 9, 1972
Carcinoembryonic antigen in the urine of patients with urothelial carcinomaR R Hall, D J Laurence, D Darcy, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2014
Support of hepatic regeneration by trophic factors from liver-derived mesenchymal stromal/stem cellsSuomi M G Fouraschen, Sean R R Hall, Jeroen de Jonge, et al.
British Journal of Urology|December 1, 1984
Treatment of invasive bladder cancer by local resection and high dose methotrexateR R Hall, D W Newling, P D Ramsden, et al.
Progress in Clinical and Biological Research|January 1, 1990
The value of the bone scanP H Smith, F Debruyne, T G Armitage, et al.
British Journal of Urology|June 1, 1994
Marker tumour response to Evans and Pasteur bacille Calmette-Guérin in multiple recurrent pTa/pT1 bladder tumours: report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)G J Fellows, M K Parmar, K M Grigor, et al.
European Urology|January 1, 1996
Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897)A P Van der Meijden, R R Hall, M P Macaluso, et al.
European Urology|January 1, 1988
A phase-II study of neoadjuvant chemotherapy in T3-4N0-XM0 transitional cell carcinoma of the bladder: a preliminary analysisT A Splinter, F H Schröder, L Denis, et al.
Pageof 16

Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Cancer|April 1, 1990
The epidermal growth factor receptor and the prognosis of bladder cancerD E Neal, L Sharples, K Smith, et al.
The Journal of Urology|May 9, 2001
Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumorsJ Palou, P Laguna, F Millán-Rodríguez, et al.
The Journal of Urology|March 1, 1989
Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand bindingD E Neal, K Smith, J A Fennelly, et al.
British Medical Journal|September 9, 1972
Carcinoembryonic antigen in the urine of patients with urothelial carcinomaR R Hall, D J Laurence, D Darcy, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2014
Support of hepatic regeneration by trophic factors from liver-derived mesenchymal stromal/stem cellsSuomi M G Fouraschen, Sean R R Hall, Jeroen de Jonge, et al.
British Journal of Urology|December 1, 1984
Treatment of invasive bladder cancer by local resection and high dose methotrexateR R Hall, D W Newling, P D Ramsden, et al.
Progress in Clinical and Biological Research|January 1, 1990
The value of the bone scanP H Smith, F Debruyne, T G Armitage, et al.
British Journal of Urology|June 1, 1994
Marker tumour response to Evans and Pasteur bacille Calmette-Guérin in multiple recurrent pTa/pT1 bladder tumours: report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)G J Fellows, M K Parmar, K M Grigor, et al.
European Urology|January 1, 1996
Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897)A P Van der Meijden, R R Hall, M P Macaluso, et al.
European Urology|January 1, 1988
A phase-II study of neoadjuvant chemotherapy in T3-4N0-XM0 transitional cell carcinoma of the bladder: a preliminary analysisT A Splinter, F H Schröder, L Denis, et al.
Pageof 16